(3R,5S)-5-methylpyrrolidin-3-ol hydrochloride, 97.0%, 1g

Benzo[d]isoxazol-3-ylmethanamine hydrochloride, 98%, 250mg

(1-(tert-Butoxycarbonyl)-1H-indol-2-yl)boronic acid, 98.0%, 5g

2,2',2'',2'''-(1R, 2R)-rel-(Cyclohexane-1,2-diylbis(azanetriyl))tetraacetic acid hydrate, 99.0%, 25g

5-(chloromethyl)-1-methyl-1H-pyrazole hydrochloride, 95.0%, 1g

6-chloro-N-(tetrahydrofuran-2-ylmethyl)-1,3-benzothiazol-2-amine, 95.0%, 500mg

quinoxaline-5-carboxylic acid, 95.0%, 10g

(S)-Piperidine-3-carboxylic acid hydrochloride, 95.0%, 10g

1-(4-Methylbenzyl)-2-oxo-1,2-dihydropyridine-3-carboxylic acid, 95.0%, 500mg

2-Methoxy-9-phenylacridine, 98%, 5g

2,6-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid, 97%, 1g

Aluminum oxide, nano, ROTI®nanoMETIC min. 99.9%, 40 nm, 50 g, glass packaging

3-Bromo-5-(difluoromethoxy)pyridine, 95%, 1g